Journal of
eISSN: 2376-0060
Submit manuscript...
Case Report Volume 4 Issue 3
Von Recklinghausen's Disease and Emphysema Case Report
Hernandez-Zenteno R,
Verify Captcha
Regret for the inconvenience: we are taking measures to prevent fraudulent form submissions by extractors and page crawlers. Please type the correct Captcha word to see email ID.
Velazquez-Montero A
Verify Captcha
Regret for the inconvenience: we are taking measures to prevent fraudulent form submissions by extractors and page crawlers. Please type the correct Captcha word to see email ID.
National Institute of Respiratory Diseases, COPD Clinic, Mexico
Correspondence: Hernandez-Zenteno R, National Institute of Respiratory Diseases, COPD Clinic, Mexico City, Mexico
Received: January 01, 2017 | Published: July 19, 2017
Citation: Hernandez-Zenteno R, Velazquez-Montero A, Trujillo FF, Monteros MC (2017) Von Recklinghausen’s Disease and Emphysema Case Report. J Lung Pulm Respir Res 4(3): 00130. DOI: 10.15406/jlprr.2017.04.00130
Keywords
Pulmonary arterial hypertension, Lung disease, Neurofibromatosis, Multipleneurofibromas, Emphysema
Case report
Female of 59 years old, exposed to biomass smoke (index=100 hrs/year), followed as Chronic Obstructive Lung Disease during 9 years; her main symptom has been dyspnea, vital signs HR 86 per min, RR 20 per min, 110/78 mmHg, body temperature 36.6°C, very severe obstruction in spirometry, low Diffusion Capacity, increased Residual Volume, Pulmonary Arterial hypertension by echocardiography (47 mmHg) and arterial gases pH 7.38, PaCO2= 47 mmHg, PaO2 66 mmHg, HCO3 =21.6 and O2 saturation 92.5% with oxygen supply. Radiographic studies Figure 1 showed, bullous emphysema at left lung in conventional chest radiography; and, neurofibromatosis lesions in both hands (Figure 2) and feet (Figure 3) and Computed tomography revealing bilateral emphysema and bullae (Figure 4).
Figure 1 Chest X ray.
Figure 2 Neurofibromatosis Lesions.
Figure 3 Bullous emphysema 1.
Figure 4 Bullous emphysema 2.
Review
Von Recklinghausen's disease or neurofibromatosis type 1 and 2 (NF1-2), is a common autosomal disorder characterized by multipleneurofibromas, cafe au lait spots, and Lisch nodules of theiris with a variable clinical systemic expression. Its prevalence estimated to be 1 in 3,000 live births, and males outnumbered females.1 Respiratory manifestations and Lung involvement in NFis a well-known complication, in only 5% of cases; the most reported symptom is dyspnea and the alterations consists of chest wall deformities, upper airway obstruction by neurofibromatosis, primary pulmonary hypertension, central hypoventilation, diaphragm paralysis, diffuse interstitial fibrosis and bullae, eitheralone or in combination. Estimated incidences of findings are for interstitial fibrosis 7-50%, bulla 18-50%, ground-glass opacities 9-37%, nodules 9%, cysts 14-25% and for mediastinal masses 14%.2-5
Smoking histories are documented in 25% of patients, but its association with NF remains controversial and unclear. In non-smoking NF occasionally a minimal micro nodular pattern of ground glass opacity is observed and less common emphysema, fibrosis, honecombing or severe bullous disease and may be entirely asymptomatic.2,3 Our particular case was exposed to significant biomass smoke, which do not have association with bullous emphysema as tobacco smoking does.
Acknowledgments
None.
Conflicts of interest
None.
References
- Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet. 1996;33(1):2‒17.
- Lovin S, Veale D. Respiratory manifestations in von Recklinghausen's disease. Pneumologia. 2005;54(4):186‒190.
- Zamora AC, Collard HR, Wolters PJ, et al. Neurofibromatosis-associated lung disease: a case series and literature review. Eur Respir J. 2007;29(1):210‒214.
- Oikonomou A, Vadikolias K, Birbilis T, et al. HRCT findings in the lungs of non-smokers with neurofibromatosis. Eur J Radiol. 2011;80(3):e520‒e523.
- Ueda K, Honda O, Satoh Y, et al. Computed tomography (CT) findings in 88 neurofibromatosis 1 (NF1) patients: Prevalence rates and correlations of thoracic findings. Eur J Radiol. 2015;4(6):1191‒1195.
©2017 Hernandez-Zenteno, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.
Citations
November is Lung Cancer Awareness Month, a vital opportunity for us to raise awareness about the dangers of lung cancer. Let’s unite to educate ourselves and others, and inspire proactive steps toward lung health. This year the motto of this event is “Stronger Together: United for Lung Cancer Awareness”. So for this occasion, the Journal of Lung, Pulmonary & Respiratory Research invites articles that emphasize the significance of lung protection. All the submissions received in the month of November will be offered with 40% discount on publication.